1. Home
  2. KAI vs TLX Comparison

KAI vs TLX Comparison

Compare KAI & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kadant Inc

KAI

Kadant Inc

N/A

Current Price

$334.62

Market Cap

3.4B

Sector

Industrials

ML Signal

N/A

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$6.41

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KAI
TLX
Founded
1991
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KAI
TLX
Price
$334.62
$6.41
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$337.50
$21.00
AVG Volume (30 Days)
116.7K
178.9K
Earning Date
02-11-2026
01-19-2026
Dividend Yield
0.41%
N/A
EPS Growth
N/A
N/A
EPS
8.65
0.04
Revenue
$1,024,074,000.00
$664,225,558.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.56
N/A
P/E Ratio
$38.56
$150.68
Revenue Growth
N/A
55.35
52 Week Low
$244.87
$6.40
52 Week High
$409.73
$30.36

Technical Indicators

Market Signals
Indicator
KAI
TLX
Relative Strength Index (RSI) 61.76 32.04
Support Level $332.95 $6.40
Resistance Level $348.22 $7.43
Average True Range (ATR) 11.63 0.24
MACD -0.31 -0.07
Stochastic Oscillator 75.60 0.24

Price Performance

Historical Comparison
KAI
TLX

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: